VSEE Relative Valuation
VSEE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VSEE is overvalued; if below, it's undervalued.
Historical Valuation
Vsee Health Inc (VSEE) is now in the Fair zone, suggesting that its current forward PS ratio of 1.00 is considered Fairly compared with the five-year average of -0.80. The fair price of Vsee Health Inc (VSEE) is between 0.25 to 0.54 according to relative valuation methord.
Relative Value
Fair Zone
0.25-0.54
Current Price:0.43
Fair
-1.17
PE
1Y
3Y
5Y
-6.86
EV/EBITDA
Vsee Health Inc. (VSEE) has a current EV/EBITDA of -6.86. The 5-year average EV/EBITDA is -1.98. The thresholds are as follows: Strongly Undervalued below -8.15, Undervalued between -8.15 and -5.07, Fairly Valued between 1.10 and -5.07, Overvalued between 1.10 and 4.19, and Strongly Overvalued above 4.19. The current Forward EV/EBITDA of -6.86 falls within the Undervalued range.
-4.27
EV/EBIT
Vsee Health Inc. (VSEE) has a current EV/EBIT of -4.27. The 5-year average EV/EBIT is -1.24. The thresholds are as follows: Strongly Undervalued below -5.11, Undervalued between -5.11 and -3.18, Fairly Valued between 0.69 and -3.18, Overvalued between 0.69 and 2.63, and Strongly Overvalued above 2.63. The current Forward EV/EBIT of -4.27 falls within the Undervalued range.
1.00
PS
Vsee Health Inc. (VSEE) has a current PS of 1.00. The 5-year average PS is 0.32. The thresholds are as follows: Strongly Undervalued below -0.70, Undervalued between -0.70 and -0.19, Fairly Valued between 0.83 and -0.19, Overvalued between 0.83 and 1.34, and Strongly Overvalued above 1.34. The current Forward PS of 1.00 falls within the Overvalued range.
-5.91
P/OCF
Vsee Health Inc. (VSEE) has a current P/OCF of -5.91. The 5-year average P/OCF is -1.79. The thresholds are as follows: Strongly Undervalued below -7.48, Undervalued between -7.48 and -4.63, Fairly Valued between 1.06 and -4.63, Overvalued between 1.06 and 3.90, and Strongly Overvalued above 3.90. The current Forward P/OCF of -5.91 falls within the Undervalued range.
-5.86
P/FCF
Vsee Health Inc. (VSEE) has a current P/FCF of -5.86. The 5-year average P/FCF is -1.77. The thresholds are as follows: Strongly Undervalued below -7.42, Undervalued between -7.42 and -4.60, Fairly Valued between 1.05 and -4.60, Overvalued between 1.05 and 3.87, and Strongly Overvalued above 3.87. The current Forward P/FCF of -5.86 falls within the Undervalued range.
Vsee Health Inc (VSEE) has a current Price-to-Book (P/B) ratio of -1.29. Compared to its 3-year average P/B ratio of -152.81 , the current P/B ratio is approximately -99.16% higher. Relative to its 5-year average P/B ratio of -95.04, the current P/B ratio is about -98.64% higher. Vsee Health Inc (VSEE) has a Forward Free Cash Flow (FCF) yield of approximately -27.18%. Compared to its 3-year average FCF yield of -19.65%, the current FCF yield is approximately 38.28% lower. Relative to its 5-year average FCF yield of -19.65% , the current FCF yield is about 38.28% lower.
-1.29
P/B
Median3y
-152.81
Median5y
-95.04
-27.18
FCF Yield
Median3y
-19.65
Median5y
-19.65
Competitors Valuation Multiple
The average P/S ratio for VSEE's competitors is 0.64, providing a benchmark for relative valuation. Vsee Health Inc Corp (VSEE) exhibits a P/S ratio of 1.00, which is 56.14% above the industry average. Given its robust revenue growth of 18.67%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of VSEE decreased by 74.64% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 3.35M to 3.98M.
The secondary factor is the P/E Change, contributed 6.24%to the performance.
Overall, the performance of VSEE in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
Frequently Asked Questions
Is Vsee Health Inc (VSEE) currently overvalued or undervalued?
Vsee Health Inc (VSEE) is now in the Fair zone, suggesting that its current forward PS ratio of 1.00 is considered Fairly compared with the five-year average of -0.80. The fair price of Vsee Health Inc (VSEE) is between 0.25 to 0.54 according to relative valuation methord.
What is Vsee Health Inc (VSEE) fair value?
VSEE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Vsee Health Inc (VSEE) is between 0.25 to 0.54 according to relative valuation methord.
How does VSEE's valuation metrics compare to the industry average?
The average P/S ratio for VSEE's competitors is 0.64, providing a benchmark for relative valuation. Vsee Health Inc Corp (VSEE) exhibits a P/S ratio of 1.00, which is 56.14% above the industry average. Given its robust revenue growth of 18.67%, this premium appears unsustainable.
What is the current P/B ratio for Vsee Health Inc (VSEE) as of Jan 08 2026?
As of Jan 08 2026, Vsee Health Inc (VSEE) has a P/B ratio of -1.29. This indicates that the market values VSEE at -1.29 times its book value.
What is the current FCF Yield for Vsee Health Inc (VSEE) as of Jan 08 2026?
As of Jan 08 2026, Vsee Health Inc (VSEE) has a FCF Yield of -27.18%. This means that for every dollar of Vsee Health Inc’s market capitalization, the company generates -27.18 cents in free cash flow.
What is the current Forward P/E ratio for Vsee Health Inc (VSEE) as of Jan 08 2026?
As of Jan 08 2026, Vsee Health Inc (VSEE) has a Forward P/E ratio of -1.17. This means the market is willing to pay $-1.17 for every dollar of Vsee Health Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Vsee Health Inc (VSEE) as of Jan 08 2026?
As of Jan 08 2026, Vsee Health Inc (VSEE) has a Forward P/S ratio of 1.00. This means the market is valuing VSEE at $1.00 for every dollar of expected revenue over the next 12 months.